Literature DB >> 6890402

Syndrome of inappropriate antidiuretic hormone secretion following dis-dichlorodiammineplatinum II in a patient with malignant thymoma.

L Levin, R Sealy, J Barron.   

Abstract

A patient with malignant thymoma is reported, in whom the syndrome of inappropriate antidiuretic hormone secretion (SIADH) occurred 36-48 hours after being given cis-Dichlorodiammineplatinum II (CPPD) with a mannitol diuresis. The SIADH was treated by fluid restriction and demeclocycline and subsided after approximately 72 hours. Subsequent courses of CPPD with mannitol diuresis were given with demeclocycline prophylactically and no untoward effects noted. The precise mechanism for the SIADH following the use of CPPD is unknown, but may be life-threatening, especially since preloading with fluid followed by forced diuresis is used when CPPD is given to avoid nephrotoxicity. The patient has survived 37 months, with 24 months of relapse-free survival following treatment with CPPD, irradiation and surgery.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6890402     DOI: 10.1002/1097-0142(19821201)50:11<2279::aid-cncr2820501109>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Syndrome of inappropriate antidiuretic hormone secretion due to treatment of lung cancer with cisplatin.

Authors:  T J Littlewood; A P Smith
Journal:  Thorax       Date:  1984-08       Impact factor: 9.139

Review 2.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

Review 3.  Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.

Authors:  T Y Chan
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

4.  The syndrome of inappropriate secretion of antidiuretic hormone by rectal cancer--a case report.

Authors:  S Murakami; S Togo; S Yasuda; M Saito; Y Mishima
Journal:  Jpn J Surg       Date:  1987-07

5.  Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia.

Authors:  Aaron C Tan; Gavin M Marx
Journal:  BMJ Case Rep       Date:  2018-01-31

6.  Combination chemotherapy of squamous cell carcinoma of the bronchus with cisplatinum and bleomycin followed by radiotherapy: results of a pilot study.

Authors:  S J Karp; T E Young; M T Bakowski; M F Spittle
Journal:  J R Soc Med       Date:  1986-10       Impact factor: 5.344

7.  Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma.

Authors:  Do Youn Kwon; Gwan Hee Han; Roshani Ulak; Kyung Do Ki; Jong Min Lee; Seon Kyung Lee
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

8.  Folinic Acid, Fluorouracil, and Oxaliplatin Therapy for Recurrent Esophageal Cancer with Syndrome of Inadequate Antidiuretic Hormone Secretion (SIADH) After Preoperative Cisplatin/5-Fluorouracil Therapy.

Authors:  Ryoko Futai; Tomoo Yoshie; Tsuyoshi Sanuki; Yuta Inoue; Tetsuyuki Abe; Ayaka Sasaki; Takao Iemoto; Hiroki Hayashi; Takayuki Ose; Teruhisa Morikawa
Journal:  Am J Case Rep       Date:  2022-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.